BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34313898)

  • 1. Physical activity volume in patients with arrhythmogenic cardiomyopathy is associated with recurrence after ventricular tachycardia ablation.
    Vergara P; Pannone L; Calvo F; Falasconi G; Foppoli L; Cireddu M; D'Angelo G; Limite L; Boccellino A; Palmisano A; Capogrosso C; Stella S; Esposito A; Agricola E; Gulletta S; Della Bella P
    J Interv Card Electrophysiol; 2022 Oct; 65(1):15-24. PubMed ID: 34313898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the arrhythmogenic substrate in patients with arrhythmogenic right ventricular cardiomyopathy undergoing ventricular tachycardia ablation.
    Kirubakaran S; Bisceglia C; Silberbauer J; Oloriz T; Santagostino G; Yamase M; Maccabelli G; Trevisi N; Della Bella P
    Europace; 2017 Jun; 19(6):1049-1062. PubMed ID: 28371837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Outcome After Ventricular Tachycardia Ablation in Nonischemic Cardiomyopathy: Late Potential Abolition and VT Noninducibility.
    Okubo K; Gigli L; Trevisi N; Foppoli L; Radinovic A; Bisceglia C; Frontera A; D'Angelo G; Cireddu M; Paglino G; Mazzone P; Della Bella P
    Circ Arrhythm Electrophysiol; 2020 Aug; 13(8):e008307. PubMed ID: 32657137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: A Sequential Approach.
    Mathew S; Saguner AM; Schenker N; Kaiser L; Zhang P; Yashuiro Y; Lemes C; Fink T; Maurer T; Santoro F; Wohlmuth P; Reißmann B; Heeger CH; Tilz R; Wissner E; Rillig A; Metzner A; Kuck KH; Ouyang F
    J Am Heart Assoc; 2019 Mar; 8(5):e010365. PubMed ID: 30813830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Outcome With Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
    Santangeli P; Zado ES; Supple GE; Haqqani HM; Garcia FC; Tschabrunn CM; Callans DJ; Lin D; Dixit S; Hutchinson MD; Riley MP; Marchlinski FE
    Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1413-21. PubMed ID: 26546346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy: Insights from the Johns Hopkins ARVC Program.
    Daimee UA; Assis FR; Murray B; Tichnell C; James CA; Calkins H; Tandri H
    Heart Rhythm; 2021 Aug; 18(8):1369-1376. PubMed ID: 33933674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catheter ablation reduces ventricular tachycardia burden in patients with arrhythmogenic right ventricular cardiomyopathy: insights from a north-western French multicentre registry.
    Souissi Z; Boulé S; Hermida JS; Doucy A; Mabo P; Pavin D; Anselme F; Auquier N; Ninni S; Coisne A; Brigadeau F; Deken-Delannoy V; Klug D; Lacroix D
    Europace; 2018 Feb; 20(2):362-369. PubMed ID: 28017936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes and ventricular tachycardia recurrence characteristics after epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Philips B; te Riele AS; Sawant A; Kareddy V; James CA; Murray B; Tichnell C; Kassamali B; Nazarian S; Judge DP; Calkins H; Tandri H
    Heart Rhythm; 2015 Apr; 12(4):716-25. PubMed ID: 25530221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catheter ablation of arrhythmogenic right ventricular cardiomyopathy ventricular tachycardia: 18-year experience in 284 patients.
    Liang E; Wu L; Fan S; Hu F; Zheng L; Liu S; Fan X; Chen G; Ding L; Niu G; Yao Y
    Europace; 2020 May; 22(5):806-812. PubMed ID: 32155249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninducibility and late potential abolition: a novel combined prognostic procedural end point for catheter ablation of postinfarction ventricular tachycardia.
    Silberbauer J; Oloriz T; Maccabelli G; Tsiachris D; Baratto F; Vergara P; Mizuno H; Bisceglia C; Marzi A; Sora N; Guarracini F; Radinovic A; Cireddu M; Sala S; Gulletta S; Paglino G; Mazzone P; Trevisi N; Della Bella P
    Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):424-35. PubMed ID: 24833642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ablation compared with drug therapy for recurrent ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy: Results from a multicenter study.
    Mahida S; Venlet J; Saguner AM; Kumar S; Baldinger SH; AbdelWahab A; Tedrow UB; Castelletti S; Pantazis A; John RM; McKenna WJ; Lambiase PD; Duru F; Sapp JL; Zeppenfeld K; Stevenson WG
    Heart Rhythm; 2019 Apr; 16(4):536-543. PubMed ID: 30366162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supraventricular arrhythmias in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy associate with long-term outcome after catheter ablation of ventricular tachycardias.
    Müssigbrodt A; Knopp H; Efimova E; Weber A; Bertagnolli L; Hilbert S; Kosiuk J; Dinov B; Bode K; Kircher S; Dagres N; Richter S; Sommer P; Husser D; Bollmann A; Hindricks G; Arya A
    Europace; 2018 Jul; 20(7):1182-1187. PubMed ID: 28595345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of catecholamine-facilitated focal ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Philips B; Madhavan S; James C; Tichnell C; Murray B; Needleman M; Bhonsale A; Nazarian S; Laurita KR; Calkins H; Tandri H
    Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):160-6. PubMed ID: 23275260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can ventricular tachycardia non-inducibility after ablation predict reduced ventricular tachycardia recurrence and mortality in patients with non-ischemic cardiomyopathy? A meta-analysis of twenty-four observational studies.
    Hu J; Zeng S; Zhou Q; Zhu W; Xu Z; Yu J; Hong K
    Int J Cardiol; 2016 Nov; 222():689-695. PubMed ID: 27521538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should all patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergo epicardial catheter ablation?
    Müssigbrodt A; Efimova E; Knopp H; Bertagnolli L; Dagres N; Richter S; Husser D; Bollmann A; Hindricks G; Arya A
    J Interv Card Electrophysiol; 2017 Mar; 48(2):193-199. PubMed ID: 27900527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Philips B; Madhavan S; James C; Tichnell C; Murray B; Dalal D; Bhonsale A; Nazarian S; Judge DP; Russell SD; Abraham T; Calkins H; Tandri H
    Circ Arrhythm Electrophysiol; 2012 Jun; 5(3):499-505. PubMed ID: 22492430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of Catheter Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy Without Background Implantable Cardioverter Defibrillator Therapy: A Multicenter International Ventricular Tachycardia Registry.
    Santangeli P; Tung R; Xue Y; Chung FP; Lin YJ; Di Biase L; Zhan X; Lin CY; Wei W; Mohanty S; Burkhardt DJ; Zado ES; Callans DJ; Marchlinski FE; Wu S; Chen SA; Natale A
    JACC Clin Electrophysiol; 2019 Jan; 5(1):55-65. PubMed ID: 30678787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catheter ablation of electrical storm in patients with arrhythmogenic right ventricular cardiomyopathy.
    Laredo M; Oliveira Da Silva L; Extramiana F; Lellouche N; Varlet É; Amet D; Algalarrondo V; Waintraub X; Duthoit G; Badenco N; Maupain C; Hidden-Lucet F; Maury P; Gandjbakhch E;
    Heart Rhythm; 2020 Jan; 17(1):41-48. PubMed ID: 31284048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late potentials abolition reduces ventricular tachycardia recurrence after ablation especially in higher-risk patients with a chronic total occlusion in an infarct-related artery.
    Di Marco A; Oloriz Sanjuan T; Paglino G; Baratto F; Vergara P; Bisceglia C; Trevisi N; Sala S; Marzi A; Gulletta S; Cireddu M; Anguera I; Della Bella P
    J Cardiovasc Electrophysiol; 2018 Aug; 29(8):1119-1124. PubMed ID: 29543365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Exercise on Outcome after Ventricular Tachycardia Ablation in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.
    Müssigbrodt A; Czimbalmos C; Stauber A; Bertagnolli L; Bode K; Dagres N; Döring M; Richter S; Sommer P; Husser D; Bollmann A; Hindricks G; Arya A
    Int J Sports Med; 2019 Sep; 40(10):657-662. PubMed ID: 31342478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.